Page last updated: 2024-11-04

sulfadiazine and Disease Exacerbation

sulfadiazine has been researched along with Disease Exacerbation in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Research Excerpts

ExcerptRelevanceReference
"Severe forms of cerebral toxoplasmosis in patients with HIV infection are characterized by a good prognosis in approximately 50% of cases."1.38Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis. ( Ait Hssain, A; Bouadma, L; da Silva, D; Klein, IF; Messika, J; Mourvillier, B; Schmidt, M; Sonneville, R; Wolff, M, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sonneville, R1
Schmidt, M1
Messika, J1
Ait Hssain, A1
da Silva, D1
Klein, IF1
Bouadma, L1
Wolff, M1
Mourvillier, B1

Other Studies

1 other study available for sulfadiazine and Disease Exacerbation

ArticleYear
Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis.
    Neurology, 2012, Oct-23, Volume: 79, Issue:17

    Topics: Adult; Antiprotozoal Agents; Comorbidity; Disease Progression; Drug Therapy, Combination; Female; Gl

2012